The value and challenges of radiomics artificial intelligence for magnetic resonance based prostate cancer imaging

The accuracy of the diagnosis and detection of prostate cancer is not yet where we want it to be. Radiomics AI can help elevate it to a standard where patients have a smaller chance to be burdened by false positive or false negative results. While useability, reproducibility and generalization are persisting limiting factors, this thesis of Jeroen Bleker presents several solutions and shows that radiomics AI has significant value besides traditional visual assessment of prostate cancer.